Oral Rivaroxaban in Children With Venous Thrombosis

NCT01684423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Active comparator
DRUG: Rivaroxaban (BAY59-7939) suspension

Sponsor

Bayer

Collaborators

[object Object]